Fundraising FoxAerogen
Galway, IE · 3 known investors
Find your way into Aerogen
Sign up to see every warm intro you have to Aerogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aerogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aerogen develops aerosol drug delivery systems for hospital and ICU use, enabling targeted delivery of proteins, peptides, and solutions to the lungs. The company is a global leader in ventilator-based aerosol drug delivery for critical care settings.
Founders & leadership
JP
John PowerFounder & CEOJohn Power founded Aerogen Ltd in 2007 following a leveraged management buyout of his strategic business unit from Nektar Therapeutics, and previously merged his medical device company Cerus Medical with Aerogen Inc in 2000. He holds degrees in computer technology, mechanical and production engineering, and an MBA from Oxford Brookes University, with over 40 years of experience in technology industries across aerospace, automation, and medical device sectors.
Investors · 3
Temasek✓ confirmed by AerogenSingapore
How we know: the company's own site · funding news · press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Aerogen do?
- Aerogen develops aerosol drug delivery systems for hospital and ICU use, enabling targeted delivery of proteins, peptides, and solutions to the lungs. The company is a global leader in ventilator-based aerosol drug delivery for critical care settings.
- Who founded Aerogen?
- Aerogen was founded by John Power.
- Who are Aerogen's investors?
- Aerogen's investors include Temasek, HealthCap, Western Technology Investment.
- Where is Aerogen headquartered?
- Aerogen is headquartered in Galway, IE.